StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.89−0.10 (-10.51%)

Close on Nov 18, 2026Market cap $31.83MP/E 8.9Yield –

biote revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

biote's revenue for the twelve months ending Jun 30, 2026 was $183.53M, down 7.8% year over year. For fiscal 2025 it was $192.22M, down 2.5% from the year before. The highest annual figure on record is $197.19M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$192.22M-2.5%
FY2024Dec 31, 2024$197.19M+6.4%
FY2023Dec 31, 2023$185.36M+12.4%
FY2022Dec 31, 2022$164.96M+18.3%
FY2021Dec 31, 2021$139.40M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$44.23M-9.5%
Q1 FY2026Mar 31, 2026$44.94M-8.3%
Q4 FY2025Dec 31, 2025$46.41M-6.9%
Q3 FY2025Sep 30, 2025$47.96M-6.7%
Q2 FY2025Jun 30, 2025$48.86M-0.6%
Q1 FY2025Mar 31, 2025$48.99M+4.7%
Q4 FY2024Dec 31, 2024$49.83M+9.0%
Q3 FY2024Sep 30, 2024$51.38M+12.8%
Q2 FY2024Jun 30, 2024$49.17M-0.2%
Q1 FY2024Mar 31, 2024$46.80M+4.4%
Q4 FY2023Dec 31, 2023$45.70M+2.7%
Q3 FY2023Sep 30, 2023$45.56M+8.5%
Q2 FY2023Jun 30, 2023$49.26M+19.1%
Q1 FY2023Mar 31, 2023$44.84M+20.7%
Q4 FY2022Dec 31, 2022$44.49M+18.5%
Q3 FY2022Sep 30, 2022$41.97M+18.0%
Q2 FY2022Jun 30, 2022$41.36M+19.0%
Q1 FY2022Mar 31, 2022$37.14M–
Q4 FY2021Dec 31, 2021$37.54M–
Q3 FY2021Sep 30, 2021$35.57M–
Q2 FY2021Jun 30, 2021$34.75M–

More biote figures

See a number that looks wrong?